Neurizon Therapeutics has entered into a global licensing deal with Elanco Animal Health to advance the development of NUZ-001 for ALS.

Reflecting on a scary road rage incident reminds columnist Kristin Neva of the fragility of life. None of us is guaranteed tomorrow.